Stock LNA LNA SANTÉ
Add to a list
To use this feature you must be a member
Log inSign up

Financials LNA Santé

Equities

LNA

FR0004170017

Healthcare Facilities & Services

Market Closed - Euronext Paris
Other stock markets
 11:35:09 2024-04-29 EDT 		5-day change 1st Jan Change
19.76 EUR +2.70% Intraday chart for LNA Santé +2.92% -1.69%
03-28 LNA Santé: 9% drop in annual RNPG CF
02-12 LNA Santé: LNA Ensemble exceeds 10% of voting rights CF

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 421.4 478.1 471.3 484.3 311 196.8 196.8 -
Enterprise Value (EV) 1 616.1 1,158 1,324 1,339 1,121 1,169 1,097 934.4
P/E ratio 19.6 x 23 x 60.5 x 20.5 x 11.9 x 8.78 x 9.12 x 6.65 x
Yield 0.87% 0.91% 0.41% 0.85% 1.69% 2.99% 2.23% 2.77%
Capitalization / Revenue 0.78 x 0.91 x 0.82 x 0.7 x 0.43 x 0.28 x 0.24 x 0.22 x
EV / Revenue 1.14 x 2.19 x 2.31 x 1.94 x 1.54 x 1.59 x 1.34 x 1.04 x
EV / EBITDA 11.7 x 10.2 x 11.4 x 9.48 x 7.85 x 7.85 x 8.5 x 5.68 x
EV / FCF 16 x 10.4 x 9.64 x 19.2 x 12.5 x 13.6 x 13.2 x 8.76 x
FCF Yield 6.24% 9.63% 10.4% 5.21% 8.02% 7.36% 7.57% 11.4%
Price to Book 2.14 x 2.53 x 2.5 x 2.23 x - 0.7 x 0.65 x 0.68 x
Nbr of stocks (in thousands) 9,677 9,650 9,569 9,629 10,508 10,227 10,227 -
Reference price 2 43.55 49.55 49.25 50.30 29.60 19.24 19.24 19.24
Announcement Date 19-04-03 20-04-01 21-03-31 22-03-30 23-03-29 24-03-27 - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 538.8 527.9 573.9 689.5 728.2 736.1 820 896.6
EBITDA 1 52.88 113.9 116.5 141.2 142.8 148.8 129 164.4
EBIT 1 43.97 55.12 51.38 64.81 64.31 65 66 75.8
Operating Margin 8.16% 10.44% 8.95% 9.4% 8.83% 8.83% 8.05% 8.45%
Earnings before Tax (EBT) 35.7 36.45 18.64 36.25 - - - -
Net income 1 21.52 20.83 7.807 23.51 25.81 23.4 22 30.47
Net margin 4% 3.95% 1.36% 3.41% 3.54% 3.18% 2.68% 3.4%
EPS 2 2.226 2.158 0.8147 2.453 2.492 2.290 2.110 2.893
Free Cash Flow 1 38.47 111.5 137.4 69.68 89.86 85.98 83 106.6
FCF margin 7.14% 21.12% 23.95% 10.11% 12.34% 11.68% 10.12% 11.89%
FCF Conversion (EBITDA) 72.74% 97.9% 117.97% 49.33% 62.91% 57.78% 64.34% 64.86%
FCF Conversion (Net income) 178.71% 535.36% 1,760.45% 296.38% 348.1% 367.42% 377.27% 350%
Dividend per Share 2 0.3800 0.4500 0.2000 0.4300 0.5000 0.6000 0.4300 0.5333
Announcement Date 19-04-03 20-04-01 21-03-31 22-03-30 23-03-29 24-03-27 - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S1 2020 S1 2021 Q2 2021 S1 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1
Net sales 1 255.5 278.3 173.6 337.3 160.1 192.1 166.4 193.5 359.9 179 189.3 177 186.7 363.7 176.6 198 185.3
EBITDA 28.69 - - - - - - - - - - - - - - - -
EBIT 22.9 21.6 - 30.9 - - - - 33.07 - - - - 32.2 - - -
Operating Margin 8.96% 7.76% - 9.16% - - - - 9.19% - - - - 8.85% - - -
Earnings before Tax (EBT) - - - - - - - - - - - - - - - - -
Net income - - - - - - - - - - - - - - - - -
Net margin - - - - - - - - - - - - - - - - -
EPS - - - - - - - - - - - - - - - - -
Dividend per Share - - - - - - - - - - - - - - - - -
Announcement Date 19-09-18 - 21-09-30 - 21-11-04 22-03-30 22-06-14 22-09-14 22-09-14 22-11-05 23-03-29 23-05-04 23-09-13 23-09-13 23-11-07 - -
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 195 680 853 854 810 963 900 738
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 3.681 x 5.972 x 7.324 x 6.048 x 5.668 x 6.472 x 6.977 x 4.487 x
Free Cash Flow 1 38.5 112 137 69.7 89.9 86 83 107
ROE (net income / shareholders' equity) 11.4% 10.8% 4.3% 11.5% 10.2% 7.95% 7.3% 11%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 20.40 19.60 19.70 22.50 - 27.30 29.50 28.20
Cash Flow per Share 2 5.240 11.30 15.30 8.330 - 14.30 11.80 12.70
Capex 1 9.55 6.53 9.07 10.2 12 11.5 15.4 16.9
Capex / Sales 1.77% 1.24% 1.58% 1.49% 1.64% 1.57% 1.87% 1.88%
Announcement Date 19-04-03 20-04-01 21-03-31 22-03-30 23-03-29 24-03-27 - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for LNA Santé

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
19.24 EUR
Average target price
32.5 EUR
Spread / Average Target
+68.92%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
LNA SANTÉ Stock LNA Santé
-1.69% 210M
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.41% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+14.77% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+11.62% 29.59B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-9.06% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-1.39% 16.36B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.58% 11.77B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+1.82% 11.72B
DAVITA INC. Stock DaVita Inc.
+30.90% 11.71B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-0.47% 11.66B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. LNA Stock
  4. Financials LNA Santé